Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,558Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 14Jardiance

02 1jardiance

PharmaCompass

01

Brand Name : Jardiance

Empagliflozin

arrow
Pharmtech & Ingredients
Not Confirmed

02

Brand Name : Jardiance

Empagliflozin

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Jardiance

arrow
Pharmtech & Ingredients
Not Confirmed

Empagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 2,954

2019 Revenue in Millions : 2,563

Growth (%) : 15

blank

03

Brand Name : Jardiance

Empagliflozin

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Jardiance

arrow
Pharmtech & Ingredients
Not Confirmed

Empagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 4,338

2020 Revenue in Millions : 3,740

Growth (%) : 25

blank

04

Brand Name : Jardiance

Empagliflozin

arrow
Pharmtech & Ingredients
Not Confirmed

05

Brand Name : Jardiance

Empagliflozin

arrow
Pharmtech & Ingredients
Not Confirmed

06

Brand Name : Jardiance

Empagliflozin

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Jardiance

arrow
Pharmtech & Ingredients
Not Confirmed

Empagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2022 Revenue in Millions : 6,322

2021 Revenue in Millions : 4,338

Growth (%) : 46

blank

07

Brand Name : Jardiance

Empagliflozin

arrow
Pharmtech & Ingredients
Not Confirmed

08

Brand Name : Jardiance

Empagliflozin

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Jardiance

arrow
Pharmtech & Ingredients
Not Confirmed

Empagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2023 Revenue in Millions : 7,856

2022 Revenue in Millions : 6,322

Growth (%) : 27

blank

09

Brand Name : Jardiance

Empagliflozin

arrow
Pharmtech & Ingredients
Not Confirmed

10

Brand Name : jardiance

Empagliflozin

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : jardiance

arrow
Pharmtech & Ingredients
Not Confirmed

Empagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2018 Revenue in Millions : 1,651

2017 Revenue in Millions : 1,139

Growth (%) : 45%

blank